Surgical staging in carcinoma of the prostate: The RTOG experience
Identifieur interne : 00F200 ( Main/Exploration ); précédent : 00F199; suivant : 00F201Surgical staging in carcinoma of the prostate: The RTOG experience
Auteurs : M. V. Pilepich ; S. O. Asbell [États-Unis] ; G. S. Mulholland [États-Unis] ; T. Pajak [États-Unis]Source :
- The Prostate [ 0270-4137 ] ; 1984.
Descripteurs français
- KwdFr :
- Attribution aléatoire, Biopsie, Carcinomes (), Carcinomes (anatomopathologie), Carcinomes (radiothérapie), Dosimétrie en radiothérapie, Humains, Lymphadénectomie, Lymphoedème (épidémiologie), Mâle, Métastase lymphatique, Noeuds lymphatiques (anatomopathologie), Stade de la tumeur, Tumeurs de la prostate (), Tumeurs de la prostate (anatomopathologie), Tumeurs de la prostate (radiothérapie), Études de suivi.
- MESH :
- anatomopathologie : Carcinomes, Noeuds lymphatiques, Tumeurs de la prostate.
- radiothérapie : Carcinomes, Tumeurs de la prostate.
- épidémiologie : Lymphoedème.
- Attribution aléatoire, Biopsie, Carcinomes, Dosimétrie en radiothérapie, Humains, Lymphadénectomie, Mâle, Métastase lymphatique, Stade de la tumeur, Tumeurs de la prostate, Études de suivi.
English descriptors
- KwdEn :
- Biopsy, Carcinoma (pathology), Carcinoma (radiotherapy), Carcinoma (surgery), Follow-Up Studies, Humans, Lymph Node Excision, Lymph Nodes (pathology), Lymphatic Metastasis, Lymphedema (epidemiology), Male, Neoplasm Staging, Prostatic Neoplasms (pathology), Prostatic Neoplasms (radiotherapy), Prostatic Neoplasms (surgery), Radiotherapy Dosage, Random Allocation.
- MESH :
- epidemiology : Lymphedema.
- pathology : Carcinoma, Lymph Nodes, Prostatic Neoplasms.
- radiotherapy : Carcinoma, Prostatic Neoplasms.
- surgery : Carcinoma, Prostatic Neoplasms.
- Biopsy, Follow-Up Studies, Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Neoplasm Staging, Radiotherapy Dosage, Random Allocation.
Abstract
One hundred thirty‐six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75–06 and RTOG 77–06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25–30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.
Url:
DOI: 10.1002/pros.2990050502
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 005D15
- to stream Istex, to step Curation: 005D15
- to stream Istex, to step Checkpoint: 006094
- to stream Main, to step Merge: 010066
- to stream PubMed, to step Corpus: 006A04
- to stream PubMed, to step Curation: 006A04
- to stream PubMed, to step Checkpoint: 006A04
- to stream Ncbi, to step Merge: 00AA76
- to stream Ncbi, to step Curation: 00AA76
- to stream Ncbi, to step Checkpoint: 00AA76
- to stream Main, to step Merge: 00FF57
- to stream Main, to step Curation: 00F200
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Surgical staging in carcinoma of the prostate: The RTOG experience</title><author><name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M. V." last="Pilepich">M. V. Pilepich</name></author><author><name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S. O." last="Asbell">S. O. Asbell</name></author><author><name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G. S." last="Mulholland">G. S. Mulholland</name></author><author><name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T." last="Pajak">T. Pajak</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C6C18515B00B36A029844B63329B3F10BFA91EB4</idno><date when="1984" year="1984">1984</date><idno type="doi">10.1002/pros.2990050502</idno><idno type="url">https://api.istex.fr/document/C6C18515B00B36A029844B63329B3F10BFA91EB4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">005D15</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005D15</idno><idno type="wicri:Area/Istex/Curation">005D15</idno><idno type="wicri:Area/Istex/Checkpoint">006094</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">006094</idno><idno type="wicri:doubleKey">0270-4137:1984:Pilepich M:surgical:staging:in</idno><idno type="wicri:Area/Main/Merge">010066</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:6483687</idno><idno type="wicri:Area/PubMed/Corpus">006A04</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006A04</idno><idno type="wicri:Area/PubMed/Curation">006A04</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006A04</idno><idno type="wicri:Area/PubMed/Checkpoint">006A04</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006A04</idno><idno type="wicri:Area/Ncbi/Merge">00AA76</idno><idno type="wicri:Area/Ncbi/Curation">00AA76</idno><idno type="wicri:Area/Ncbi/Checkpoint">00AA76</idno><idno type="wicri:doubleKey">0270-4137:1984:Pilepich M:surgical:staging:in</idno><idno type="wicri:Area/Main/Merge">00FF57</idno><idno type="wicri:Area/Main/Curation">00F200</idno><idno type="wicri:Area/Main/Exploration">00F200</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Surgical staging in carcinoma of the prostate: The RTOG experience</title><author><name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M. V." last="Pilepich">M. V. Pilepich</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">63108</wicri:noCountry></affiliation></author><author><name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S. O." last="Asbell">S. O. Asbell</name><affiliation wicri:level="3"><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>Albert Einstein Medical Center</wicri:orgArea></affiliation></author><author><name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G. S." last="Mulholland">G. S. Mulholland</name><affiliation wicri:level="3"><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>Thomas Jefferson University</wicri:orgArea></affiliation></author><author><name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T." last="Pajak">T. Pajak</name><affiliation wicri:level="3"><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>RTOG Headquarters</wicri:orgArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">The Prostate</title><title level="j" type="alt">PROSTATE, THE</title><idno type="ISSN">0270-4137</idno><idno type="eISSN">1097-0045</idno><imprint><biblScope unit="vol">5</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="471">471</biblScope><biblScope unit="page" to="476">476</biblScope><biblScope unit="page-count">6</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="1984">1984</date></imprint><idno type="ISSN">0270-4137</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0270-4137</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biopsy</term><term>Carcinoma (pathology)</term><term>Carcinoma (radiotherapy)</term><term>Carcinoma (surgery)</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Metastasis</term><term>Lymphedema (epidemiology)</term><term>Male</term><term>Neoplasm Staging</term><term>Prostatic Neoplasms (pathology)</term><term>Prostatic Neoplasms (radiotherapy)</term><term>Prostatic Neoplasms (surgery)</term><term>Radiotherapy Dosage</term><term>Random Allocation</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Attribution aléatoire</term><term>Biopsie</term><term>Carcinomes ()</term><term>Carcinomes (anatomopathologie)</term><term>Carcinomes (radiothérapie)</term><term>Dosimétrie en radiothérapie</term><term>Humains</term><term>Lymphadénectomie</term><term>Lymphoedème (épidémiologie)</term><term>Mâle</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Stade de la tumeur</term><term>Tumeurs de la prostate ()</term><term>Tumeurs de la prostate (anatomopathologie)</term><term>Tumeurs de la prostate (radiothérapie)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinomes</term><term>Noeuds lymphatiques</term><term>Tumeurs de la prostate</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma</term><term>Lymph Nodes</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoma</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinomes</term><term>Tumeurs de la prostate</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biopsy</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Male</term><term>Neoplasm Staging</term><term>Radiotherapy Dosage</term><term>Random Allocation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Attribution aléatoire</term><term>Biopsie</term><term>Carcinomes</term><term>Dosimétrie en radiothérapie</term><term>Humains</term><term>Lymphadénectomie</term><term>Mâle</term><term>Métastase lymphatique</term><term>Stade de la tumeur</term><term>Tumeurs de la prostate</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">One hundred thirty‐six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75–06 and RTOG 77–06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25–30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region><settlement><li>Philadelphie</li></settlement></list><tree><noCountry><name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M. V." last="Pilepich">M. V. Pilepich</name></noCountry><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S. O." last="Asbell">S. O. Asbell</name></region><name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G. S." last="Mulholland">G. S. Mulholland</name><name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T." last="Pajak">T. Pajak</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00F200 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00F200 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:C6C18515B00B36A029844B63329B3F10BFA91EB4
|texte= Surgical staging in carcinoma of the prostate: The RTOG experience
}}
| This area was generated with Dilib version V0.6.31. |  |